Arcturus Therapeutics
ARCT
37 hedge funds and large institutions have $89.2M invested in Arcturus Therapeutics in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
16% more funds holding
Funds holding: 32 → 37 (+5)
7% more capital invested
Capital invested by funds: $83.2M → $89.2M (+$6.05M)
31% less call options, than puts
Call options by funds: $272K | Put options by funds: $395K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Hayman Capital Management
Dallas,
Texas
|
+$4.7M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$4.17M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$2.31M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$2.28M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$733K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$1.13M |
| 2 |
DM
Deerfield Management
New York
|
-$685K |
| 3 |
BC
Broadfin Capital
New York
|
-$171K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$150K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$56.4K |
ARCT Hedge Fund Activity: Q3 2015 in Review
37 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q3 2015, worth a combined $89.2M — up 7.3% from $83.2M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ARCT positions and 5 closed out — a net gain of 5 holders — while 12 added to existing stakes and 9 trimmed.
The largest buyer was Hayman Capital Management, opening a new position worth an estimated $4.7M. The largest seller was Baker Bros. Advisors, cutting an estimated $1.13M.
- 37 institutional investors held Arcturus Therapeutics (ARCT) as of Q3 2015, up from 32 in Q2 2015.
- Funds reported $89.2M of Arcturus Therapeutics stock for Q3 2015, up 7.3% quarter-over-quarter.
- 10 funds opened new Arcturus Therapeutics positions in Q3 2015 and 5 closed out, a net change of +5 holders.
- The largest Arcturus Therapeutics buyer in Q3 2015 was Hayman Capital Management, an estimated $4.7M added.
- The largest Arcturus Therapeutics seller in Q3 2015 was Baker Bros. Advisors, an estimated $1.13M sold.
Based on aggregated 13F filings for Q3 2015.